Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34559223

Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood Adv
Publication date
2021 Dec 28
First author
Forlenza CJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Forlenza CJ
      type
      Author
    2. name
      Gulati N
      type
      Author
    3. name
      Mauguen A
      type
      Author
    4. name
      Absalon MJ
      type
      Author
    5. name
      Castellino SM
      type
      Author
    6. name
      Franklin A
      type
      Author
    7. name
      Keller FG
      type
      Author
    8. name
      Shukla N
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Forlenza CJ
      type
      Author
    2. name
      Gulati N
      type
      Author
    3. name
      Mauguen A
      type
      Author
    4. name
      Absalon MJ
      type
      Author
    5. name
      Castellino SM
      type
      Author
    6. name
      Franklin A
      type
      Author
    7. name
      Keller FG
      type
      Author
    8. name
      Shukla N
      type
      Author
    bibliography ids
    1. nci-bib-b0e54c708c50c039831f6f89
    book metadata
    content sha256
    e8f67ec4b749d5f069445a35ab72eacbb572cf93e942758f3b6396cd300a0ab5
    document type
    citation
    dois
    1. 10.1182/bloodadvances.2021005268
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:34559223
    immutable id
    pubmed:34559223@e8f67ec4b749d5f069445a35ab72eacbb572cf93e942758f3b6396cd300a0ab5
    journal
    abbreviation
    Blood Adv
    issn electronic
    2473-9537
    issn print
    2473-9529
    issue
    24
    name
    Blood advances
    nlm unique id
    101698425
    pages
    5519-5524
    volume
    5
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      34559223
      provenance
      batch id
      192b6392c165c6b06274
      provider
      NCBI PubMed ESummary
      record sha256
      30b762719c556df7e3a5a88b0865b9410167a743fe92e9324cf4215c62127fc5
      response sha256
      7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
      retrieved at
      2026-09-09T23:48:02.713075+00:00
      publication date
      display
      2021 Dec 28
      precision
      day
      year
      2021
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/34559223/
      title
      Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma.

      Preserved source evidence · Not medical advice